Mansukh Mandaviya holds meeting with Dr Reddy's Lab Chairman on Sputnik V production, supply
Dr Reddy's, which has tied up with Russian Direct Investment Fund (RDIF) for Sputnik V in India, soft launched the vaccine in India in May 2021, after receiving Emergency Use Authorization (EUA) in April 2021.
The Hyderabad-based drug major has already stated that the locally manufactured Sputnik V will be available from September-October period.
Sputnik V uses two different vectors for the two shots in a course of vaccination. Its efficacy was determined to be 91.6 per cent as per an article published in the medical journal Lancet.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)